Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesa Laboratories (MLAB) Cash & Current Investments (2016 - 2025)

Historic Cash & Current Investments for Mesa Laboratories (MLAB) over the last 16 years, with Q4 2025 value amounting to $30.5 million.

  • Mesa Laboratories' Cash & Current Investments rose 631.91% to $30.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was $30.5 million, marking a year-over-year increase of 631.91%. This contributed to the annual value of $29.1 million for FY2025, which is 345.05% down from last year.
  • Mesa Laboratories' Cash & Current Investments amounted to $30.5 million in Q4 2025, which was up 631.91% from $21.9 million recorded in Q3 2025.
  • Mesa Laboratories' Cash & Current Investments' 5-year high stood at $278.3 million during Q3 2021, with a 5-year trough of $21.9 million in Q3 2025.
  • Its 5-year average for Cash & Current Investments is $69.1 million, with a median of $32.1 million in 2023.
  • In the last 5 years, Mesa Laboratories' Cash & Current Investments surged by 22423.81% in 2021 and then plummeted by 8736.44% in 2022.
  • Quarter analysis of 5 years shows Mesa Laboratories' Cash & Current Investments stood at $51.7 million in 2021, then plummeted by 46.23% to $27.8 million in 2022, then increased by 9.22% to $30.4 million in 2023, then fell by 5.62% to $28.7 million in 2024, then increased by 6.32% to $30.5 million in 2025.
  • Its Cash & Current Investments stands at $30.5 million for Q4 2025, versus $21.9 million for Q3 2025 and $23.0 million for Q2 2025.